Clearing Clouds

There’s a lot of bad news swirling around the pharmaceutical industry today. Underneath the flotsam of scandal, price-fixing, and whatever-else-have-you, there is also good news. Lives are being changed. Here is my story: ———— Patient: “Doctor, I’m finally ready to at least consider whether this depressiveness is an organic problem.” Doctor: “Well, it certainly is [...]

Read Full Post »

The Friday Collection for Sept. 28

Rx Intelligence Ketamine for depression? (part 2) Some weeks back, we linked to an earlier post about this interesting potential avenue for depression treatment. Here is a follow-up (from bookofjoe.com) If you haven’t signed up yet for the Pharmaceutical Sales Training Summit (Oct 19-20), now is the time to get on board! More on the [...]

Read Full Post »

Pages: The Whistleblower

Dr. Peter Rost recently released this book, subtitled “Confessions of a Healthcare Hitman.” The Whistleblower describes his experience as a pharmaceutical executive with three different companies (Wyeth, Pharmacia, and Pfizer), focusing on some questionable practices that went on behind the scenes, and his efforts to cope with the legal and professional ramifications. It’s engaging reading, [...]

Read Full Post »

“So, what are you trying to accomplish?”

With some variations, the favorite question I get to ask as a consultant. Yesterday, I had the opportunity to ask that question (and others) with two clients who are seeking to meet their upcoming training needs. What an enjoyable day it was…one of the main reasons I launched this business was that I discovered over [...]

Read Full Post »

The Friday Collection for Sept. 21

Rx Intelligence It’s been a BIG week for acquisitions… Merck (Germany) and Serono Nycomed and Altana Hospira and Mayne Some interesting progress on the diagnostics front (another small step in the pursuit of personalized medicine). Another article from Forbes here. Getting tired of the endless drumbeat of negative press about the pharmaceutical industry? So am [...]

Read Full Post »

Wanted: Good News

I don’t know about you, but I’m pretty fed up with all the bad news about the pharmaceutical industry. Everyone wants to beat up on “Big Pharma.” One-sided hatchet jobs by those bright lights of truth, Big Media. Endless lawsuits (many of dubious merit) by those paragons of virtue, Big Tort Bar. Pompous bloviations by [...]

Read Full Post »

Pages: The End of Medicine

Just finished reading “The End of Medicine,” an interesting book by Andy Kessler. Kessler made his shekels in Silicon Valley, and decided to see if some of what he learned about successful business could be applied to the healthcare industry. Irreverent, funny, and approachable, the book details his quest to understand new trends in medical [...]

Read Full Post »

Making impact with simulations

Having just enjoyed a very engaging session on the use of Simulations (put on by the mid-NJ ASTD Sales Training Special Interest Group), I am re-energized by the potential for this approach in pharma training. The technology for creating quality (on-line) simulations quickly has really advanced in the past few years, and I can’t help [...]

Read Full Post »

The Friday Collection for Sept. 15

Rx Intelligence Another major medical center (Stanford) bans pharma industry gifts. Stunning animation of the goings-on inside of a cell. The only thing missing is an explanation of what is happening, but some kind soul supplied that here. For those seeking to keep on the medical devices field – the e-newsletter of AdvaMed, the advocacy [...]

Read Full Post »

The Friday Collection for Sept. 8

Rx Intelligence A Cancer Focus today…. A very nicely-done, public-accessible multimedia tutorial on cancer can be found here. Gardasil: maybe better than first thought?? A “spicy” future treatment? Training Intelligence For NJ area folks, an ASTD meeting focusing on the use of Simulations in Sales Training (hope to see you there!). Sign up at the [...]

Read Full Post »